Skip to main content

Table 1 Patient characteristics

From: Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort

 

No dyspnea (n = 41)

Dyspnea (n = 35)

Demographics

Age

60 ± 16

63 ± 16

Male

27 (66)

20 (57)

Ever smoker

10 (25)

13 (37)

Comorbidities

Cardiac

4 (10)

10 (29)

Pulmonary

6 (15)

10 (29)

Renal

2 (5)

5 (14)

Diabetes

11 (27)

7 (20)

Hypertension

15 (37)

11 (31)

Dyslipidemia

12 (29)

12 (34)

Malignancy

4 (10)

4 (11)

COVID-19 infection characteristics

Admission to hospital

40 (98)

34 (97)

Length of admission in days

6.5 (5–11)

11 (5–17)

Length of oxygen requirements in days

5 (3–11)

11 (7–19)

ICU/HAU admission

19 (46)

17 (49)

Mechanical ventilation

7 (17)

6 (17)

  1. Data shown are mean ± standard deviation, median (interquartile range), or number (%). Dyspnea was defined as a UCSD score > 10 at 12 months post-COVID-19. Pulmonary comorbidity was defined as any formally diagnosed lung parenchymal, pulmonary vascular, pleural, airway, or sleep-related abnormality. Cardiac comorbidity was defined as any formally diagnosed coronary artery disease, valvular abnormality, heart failure, cardiomyopathy, or arrythmia. Malignancy was defined as any formally diagnosed malignant tumour